logo

Canadian News

Share

pharma-daily-071118.jpg Today's Daily Dose brings you news about IPOs of Crinetics Pharma and Rubius; secondary offerings of Cara, Oragenics and CytomX, and promising efficacy of Cellectar Biosciences' drug candidate CLR 131 observed in a single patient in a phase II trial.

Dutch paints and chemicals maker AkzoNobel N.V. (AKZA.AS; AKZOY) Wednesday reported that net income from total operations for the second quarter slid to 271 million euros from 301 million euros last year. The results include 164 million euros in discontinued operations, compared to last year's 134...

pharma-july17.jpg The following are some of today's top gainers in the pharma/biotech sector.

Saputo Inc. (SAP.TO) said it has entered into an agreement with Bega Cheese Limited (BGA.AX) to sell its Koroit plant in Victoria, Australia for about C$244 million or A$250 million in cash. The transaction is subject to approval by the Australian Competition and Consumer Commission and is expected...

Canadian stocks shrugged off a negative start and ended modestly higher on Tuesday, led by gains in consumer discretionary, information technology and materials sectors. Due to a lack of positive lead from Asian and European markets,

The Canadian stock market is down again Tuesday morning. The continued weakness in crude oil prices is weighing on shares of energy stocks. Trading activity is rather subdued as investors monitor the first day of Federal Reserve Chairman Jerome Powell testimony before Congress. Investors are hoping for...

Canadian stocks are likely to open on a sluggish note on Tuesday, tracking losses in Asian markets and a largely subdued trend in Europe ahead of Federal Reserve Chair Jerome Powell's Congressional testimony. Powell's testimony before the Senate Banking Committee, scheduled at 10 AM ET., is expected...

pharma-daily-071618.jpg Today's Daily Dose brings you news about the resignation of Bellicum Pharma's CFO; Evolus' stock offering; Nevro's preliminary revenue figures for the second quarter of 2018 and full year outlook; FDA clearance of Quidel's new test and Spero's BARDA funding.

pharma-gainers-071817.jpg The following are some of today's top gainers in the pharma/biotech sector.

The Canadian stock market is under pressure at the start of the new trading week. Energy stocks are falling along with crude oil prices after U.S. Treasury Secretary Steve Mnuchin revealed some oil imports could receive waivers to continue buying Iranian crude despite U.S. sanctions. Markets in Europe...

GGP Inc. (GGP) reiterated the recommendation of its Board, following the unanimous recommendation of the Special Committee of GGP's Board, that the company's stockholders vote for the merger proposal with Brookfield Property Partners L.P. The company also advised stockholders to vote in favor of: the...

German gas and engineering company Linde AG (LDE.L, LNAGF.PK) said it has entered into an agreement to sell the majority of its gases business in North America and certain business activities in South America to a consortium comprising companies of German industrial gases manufacturer Messer Group and...

The U.S. dollar declined against its major counterparts in pre-European deals on Monday. The greenback dropped to a 4-day low of 1.0005 against the franc, from a high of 1.0024 hit at 7:10 pm ET. Reversing from an early high of 0.6758 against the kiwi, the greenback edged down to 0.6783. The...

ipo-july16.jpg The IPO activity in the U.S. pharma/biotech sector had a strong showing last quarter (Q2) with 24 listings compared to 13 in the year-ago period. There has not been a single biotech IPO for the month of July so far. But that is about to change.

pharma-july2-071318.jpg Here are some of the pharma/biotech stocks and upcoming events to keep an ear out for in the coming week.

Follow RTT